Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-01 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.370 | -0.640 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DYN | Dyne Therapeutics | -0.64% | 802.7M |
Dyne Therapeutics Company Questions & Answers
Q
How do I buy Dyne Therapeutics (DYN) stock?
A
You can purchase shares of Dyne Therapeutics (NASDAQ: DYN) through any online brokerage.
Q
Who are Dyne Therapeutics's (DYN) main competitors?
A
There are no as such competitors for Dyne Therapeutics.
Q
What is the target price for Dyne Therapeutics?
A
The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by JP Morgan on 2020-10-12. The analyst firm set a price target for 27.00 expecting DYN to rise to within 12 months (a possible 73.08% upside). 4 analyst firms have reported ratings in the last year.
Q
How much is Dyne Therapeutics (DYN) stock ?
A
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $15.6 last updated Fri Mar 05 2021 21:00:01 GMT+0000 (Coordinated Universal Time).
Q
When is the next Dyne Therapeutics (DYN) dividend?
A
There are no upcoming dividends for Dyne Therapeutics.
Q
When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?
A
Dyne Therapeutics’s Q1 earnings are confirmed from now on May 1, 2021.
Q
When is the upcoming split for DYN?
A
There is no upcoming split for Dyne Therapeutics.